← All companies

CRMD

CorMedix Inc.

CRMD Nasdaq Pharmaceutical Preparations EDGAR ↗

$7.55

+0.06 +0.80%

Key statistics

from XBRL data in SEC filings

Market cap

$592M

Revenue (TTM)

$400M

Net income (TTM)

$181M

EPS (TTM)

$2.17

P/E ratio

3.5

Dividend yield

—

Free cash flow

$173M

Cash

$178M

Total assets

$816M

Gross margin

85.8%

52-week range

$6.13 – $14.96

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Other events Jul 2, 2026 8-K Changed accountants Jul 1, 2026 8-K Shareholder vote results Jun 24, 2026 8-K Regulation FD disclosure Jun 8, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Results of operations (earnings release) May 14, 2026 8-K Regulation FD disclosure Apr 27, 2026 8-K Regulation FD disclosure Mar 6, 2026 10-K Fiscal year ended 2025-12-31 Mar 5, 2026 8-K Results of operations (earnings release) Mar 5, 2026 8-K Results of operations (earnings release); Director or officer change; Other events Jan 8, 2026 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Results of operations (earnings release) Nov 12, 2025 8-K Results of operations (earnings release) Oct 20, 2025 8-K/A AMENDMENT NO. 1 TO FORM 8-K Sep 30, 2025 8-K Entered a material agreement; Completed an acquisition or disposition; Unregistered sale of equity; Director or officer change; Regulation FD disclosure Sep 2, 2025 8-K Entered a material agreement; Unregistered sale of equity Aug 12, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Entered a material agreement; Results of operations (earnings release); Unregistered sale of equity; Regulation FD disclosure; Other events Aug 7, 2025 8-K Other events Jun 30, 2025 8-K Shareholder vote results Jun 25, 2025 8-K Regulation FD disclosure Jun 23, 2025 10-Q Quarter ended 2025-03-31 May 6, 2025 8-K Results of operations (earnings release) May 6, 2025 8-K Changed accountants Apr 22, 2025 8-K Results of operations (earnings release) Apr 8, 2025 10-K Fiscal year ended 2024-12-31 Mar 25, 2025 8-K Results of operations (earnings release) Mar 25, 2025 8-K Results of operations (earnings release) Jan 7, 2025 8-K Director or officer change; Shareholder vote results Nov 25, 2024 10-Q Quarter ended 2024-09-30 Oct 30, 2024 8-K Results of operations (earnings release) Oct 30, 2024 10-Q Quarter ended 2024-06-30 Aug 14, 2024 8-K Results of operations (earnings release) Aug 14, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Results of operations (earnings release) May 9, 2024 10-K Fiscal year ended 2023-12-31 Mar 12, 2024 8-K Results of operations (earnings release) Mar 12, 2024 8-K Other events Jan 30, 2024 8-K Director or officer change Dec 15, 2023